|
1
|
TNF superfamily in inflammatory disease: translating basic insights.
|
Trends Immunol
|
2011
|
1.29
|
|
2
|
4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines.
|
Cancer Res
|
2010
|
1.21
|
|
3
|
Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.
|
Curr Opin Investig Drugs
|
2007
|
1.19
|
|
4
|
A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity.
|
Vaccine
|
2009
|
1.09
|
|
5
|
Cutting edge: 4-1BB controls regulatory activity in dendritic cells through promoting optimal expression of retinal dehydrogenase.
|
J Immunol
|
2012
|
0.90
|
|
6
|
SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model.
|
Vaccine
|
2010
|
0.84
|
|
7
|
ProtEx technology for the generation of novel therapeutic cancer vaccines.
|
Exp Mol Pathol
|
2009
|
0.79
|